Literature DB >> 9369495

Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.

G D Luker1, V V Rao, C L Crankshaw, J Dahlheimer, D Piwnica-Worms.   

Abstract

The multidrug resistance (MDR1) P-glycoprotein functions as a broad specificity efflux transporter of structurally diverse natural product and xenobiotic compounds. P-glycoprotein also is an important component of the functional blood-brain barrier. To enable further studies of function and modulation of MDR1 P-glycoprotein in vitro and in vivo, two novel phosphine technetium(III) complexes were designed and characterized: trans-[2,2'-(1, 2-ethanediyldiimino)bis(1, 5-methoxy-5-methyl-4-oxo-hexenyl)]bis[methylbis(3-methoxy-1- propyl)ph osphine]Tc(III) (Tc-Q58) and trans-[5,5'-(1,2-ethanediyl diimino)bis(2-ethoxy-2-methyl-3-oxo-4-pentenyl)]bis[dimethyl(3- methox y-1-propyl)phosphine)]Tc(III) (Tc-Q63). In human drug-sensitive KB 3-1 cells and multidrug-resistant KB 8-5 and 8-5-11 derivative cell lines, expressing nonimmunodetectable, low, and high levels of MDR1 P-glycoprotein, respectively, accumulation of Tc-Q58 and Tc-Q63 was inverse to expression of the transporter. Differences between drug-sensitive and multidrug-resistant cells, while detectable at picomolar concentrations of each radiopharmaceutical, were independent of tracer concentration. Ratios of tracer accumulation in KB 3-1 and 8-5 cells were 62.3 and 48.1 for Tc-Q58 and Tc-Q63, respectively. Cell contents of Tc-Q58 and Tc-Q63 were enhanced up to 60-fold in MDR cells by known modulators of MDR1 P-glycoprotein, while drugs not in the multidrug-resistant phenotype had no effect on their accumulation. In KB 8-5 cells, potency of modulators was GF120918 >> cyclosporin A > verapamil. Accumulation of Tc-Q58 and Tc-Q63 in Sf9 insect cells infected with a recombinant baculovirus containing human MDR1 P-glycoprotein was reduced in a GF120918-reversible manner (EC50 </= 70 nM) compared with cells infected with a wild-type baculovirus. By contrast, cell contents of Tc-Q58 or Tc-Q63 in Sf9 cells expressing the homologous MDR3 P-glycoprotein did not differ from wild-type virus. Demonstrating molecular targeting of these complexes in vivo, distribution and retention of Tc-Q58 in brain tissue of FVB mice treated with a saturating dose of GF120918 and mice deficient in the mdr1a gene [mdr1a (-/-)] were enhanced 180% and 520% over control, respectively. Exploiting the gamma-emission spectrum of 99mTc, increased uptake of Tc-Q58 in brain tissue of mdr1a (-/-) mice was readily detected noninvasively by scintigraphic imaging. Thus, both Tc-Q58 and Tc-Q63 are demonstrated to be substrates for transport by MDR1 P-glycoprotein, broadening the specificity of this transporter to include phosphine-containing metal complexes. As shown with Tc-Q58, these Q complexes can be used to detect transport activity and modulation of MDR1 P-glycoprotein in vitro and to directly monitor the functional status of P-glycoprotein at the blood-brain barrier in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369495     DOI: 10.1021/bi971931z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Pathways of As(III) detoxification in Saccharomyces cerevisiae.

Authors:  M Ghosh; J Shen; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.

Authors:  Lipeng Wang; Markos Leggas; Mamta Goswami; Philip E Empey; Patrick J McNamara
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

3.  Cell-based and in vivo spectral analysis of fluorescent proteins for multiphoton microscopy.

Authors:  Emma Salomonnson; Laura Anne Mihalko; Vladislav V Verkhusha; Kathryn E Luker; Gary D Luker
Journal:  J Biomed Opt       Date:  2012-09       Impact factor: 3.170

4.  Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

Authors:  V V Rao; J L Dahlheimer; M E Bardgett; A Z Snyder; R A Finch; A C Sartorelli; D Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies.

Authors:  Shinro Matsuo; Ichiro Nakae; Takayoshi Tsutamoto; Noriake Okamoto; Minoru Horie
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

6.  Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.

Authors:  J W Polli; J L Jarrett; S D Studenberg; J E Humphreys; S W Dennis; K R Brouwer; J L Woolley
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

7.  P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.

Authors:  John R Cirrito; Rashid Deane; Anne M Fagan; Michael L Spinner; Maia Parsadanian; Mary Beth Finn; Hong Jiang; Julie L Prior; Abhay Sagare; Kelly R Bales; Steven M Paul; Berislav V Zlokovic; David Piwnica-Worms; David M Holtzman
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

8.  Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.

Authors:  Shuang Liu; Young-Seung Kim; Shizhen Zhai; Jiyun Shi; Guihua Hou
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

9.  Imaging chemokine receptor dimerization with firefly luciferase complementation.

Authors:  Kathryn E Luker; Mudit Gupta; Gary D Luker
Journal:  FASEB J       Date:  2008-11-10       Impact factor: 5.191

10.  A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.

Authors:  Vijay Sharma; Jothilingam Sivapackiam; Scott E Harpstrite; Julie L Prior; Hannah Gu; Nigam P Rath; David Piwnica-Worms
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.